ArticleOncotarget2015
The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin.
José Luis Ordóñez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
54 papers cite it
this papercites it
ArticleOncotarget2015
José Luis Ordóñez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.